DDW Events: SLAS2023 Episode 2

<p class="MsoNormal" style="line-height: 150%;"><span style= "font-size: 11.0pt; line-height: 150%; font-family: 'Arial',sans-serif;"> Ahead of this year’s SLAS2023 conference in San Diego (which takes place 25 February – 1 March) DDW’s Megan Thomas narrates articles from the DDW</span> <a href= "https://www.ddw-online.com/exclusive-ddw-slas2023-supplement-out-now-21546-202301/"> <span style= "font-size: 11.0pt; line-height: 150%; font-family: 'Arial',sans-serif;"> SLAS2023 supplement</span></a> <span style= "font-size: 11.0pt; line-height: 150%; font-family: 'Arial',sans-serif;"> as part of the DDW Events podcast series.</span></p> <p class="MsoNormal" style="line-height: 150%;"><span style= "font-size: 11.0pt; line-height: 150%; font-family: 'Arial',sans-serif;"> This is episode two,</span> Acquiring deeper insights and acceleration with AI. <span style= "font-size: 11.0pt; line-height: 150%; font-family: 'Arial',sans-serif;"> At IBM Research, a group of scientists and researchers from around the globe is working to support the power of the scientific method to invent what’s next for IBM, its clients, and the world. Joshua Smith, from the IBM T.J. Watson Research Center, spoke with me about AI, and the acceleration and discovery of therapeutics and biomarkers.</span></p>